FDA OKs Smart Watch for Epilepsy Patients — Embrace device detects grand mal, tonic-clonic seizures
/The FDA cleared marketing for Embrace, a smart watch that helps epilepsy patients and caregivers monitor seizures.
Read MoreThe FDA cleared marketing for Embrace, a smart watch that helps epilepsy patients and caregivers monitor seizures.
Read MoreThe FDA recently announced a wide-ranging Digital Health Innovation Plan that will focus on cultivating discovery across the medical field.
Read MoreThe Food and Drug Administration has issued a warning that it has confirmed cybersecurity vulnerabilities in St. Jude Medical’s implantable cardiac devices and its Merlin@home transmitter.
Read MoreThe Rehabilitation Engineering Research Center for Information and Communications Technology Access (LiveWell RERC) is funded by a 5-year grant from the National Institute on Disability, Independent Living and Rehabilitation Research in the U.S. Department of Health and Human Services (grant number 90RE5028). The opinions contained in this website are those of the LiveWell RERC and do not necessarily reflect those of the U.S. Department of Health and Human Services or NIDILRR.